Rachel Haurwitz Ph.D. — Co-Founder at Intellia Therapeutics | Comparably
Intellia Therapeutics Claimed Company
Intellia Therapeutics is a leading genome editing company focused on developing proprietary, curative therapeutics using the CRISPR/Cas9 system. Intellia believes the CRISPR/Cas9 technology has the potential to transform medicine by permanently editing disease-associated genes in the human body with a single treatment course, and through improved cell therapies that can treat cancer and immunological diseases, or can replace patients’ diseased cells. The combination of deep scientific, technical and clinical development experience, along with its leading intellectual property portfolio, puts Intellia in a unique position to unlock broad therapeutic applications of the CRISPR/Cas9 technology and create a new class of therapeutic products. read more
EMPLOYEE
PARTICIPANTS
12
TOTAL
RATINGS
170
HR or Marketing? Claim Your Free Employer Account
Rachel Haurwitz Ph.D. — Co-Founder at Intellia Therapeutics

Rachel Haurwitz Ph.D. — Co-Founder at Intellia Therapeutics

Executive Bio

Ms. Rachel Haurwitz, PhD has been the President and Chief Executive Officer at Caribou Biosciences, Inc. since 2011. Ms. Haurwitz co-founded Caribou Biosciences, Inc. in 2011. Ms. Haurwitz is a Co-Founder of Intellia Therapeutics Inc. She serves as a Director at Caribou Biosciences, Inc. She served as a Director of Intellia Therapeutics Inc. from May 2014 to November 1, 2016 and served as its Member of Scientific Advisor Board. She is an inventor on several patents and patent applications covering multiple CRISPR-derived technologies and she has co-authored scientific papers in high impact journals characterizing CRISPR-Cas systems. She has a research background in CRISPR biology and in 2014, she was named by Forbes to the ???30 Under 30??? list in Science and Healthcare. She earned an A.B. in Biological Sciences from Harvard College and received a Ph.D. in Molecular and Cell Biology from the University of California, Berkeley.

Executive Team Culture Ratings from Intellia Therapeutics Employees

TOP
30%
Intellia Therapeutics' Executive Team scores in the Top 30%
of similar sized companies on Comparably
Who ranks the Executive Team the highest?
Not Enough Ratings To Show Who Ranks Executive Team the Highest
Anonymously rate my experience at Intellia Therapeutics
Who ranks the Executive Team the lowest?
Not Enough Ratings To Show Who Ranks Executive Team the Lowest
Anonymously rate my experience at Intellia Therapeutics

Intellia Therapeutics' Executive Team at a Glance

Based on 10 ratings, Intellia Therapeutics' employees are satisfied with their Executive Team and give them a ā€œBā€ or 73/100.

Intellia Therapeutics' Executive Team ranks in the Top 35% of other companies in Boston and Top 30% of other companies on Comparably that also have 201-500 Employees.

×
Rate your company